EcoR1 Capital’s Aardvark Therapeutics AARD Stock Holding History
Bought
Maintained
Sold
Other funds holding AARD
EcoR1 Capital's AARD Position: Q3 2026 in Review
EcoR1 Capital increased its Aardvark Therapeutics (AARD) stake by 82% in Q3 2026, buying an estimated $1.98M and bringing the position to 720,028 shares worth $3.79M. The position accounts for 0.17% of the portfolio, ranked #30.
EcoR1 Capital first reported a position in AARD in Q2 2026 and has held it in 2 quarters since. 76 funds tracked by Wall St. Rank hold AARD as of Q3 2026.
- EcoR1 Capital held 720,028 shares of Aardvark Therapeutics worth $3.79M as of Q3 2026.
- EcoR1 Capital bought 323,834 Aardvark Therapeutics shares in Q3 2026, an estimated $1.98M.
- Aardvark Therapeutics made up 0.17% of EcoR1 Capital's portfolio in Q3 2026, its #30 holding.
- EcoR1 Capital first reported a position in Aardvark Therapeutics in Q2 2026 and has held it in 2 quarters since.
- 76 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q3 2026.
Based on EcoR1 Capital's 13F filing for Q3 2026, filed 16 Nov 2026.